Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81
Person › Details

Peter Hanns Zobel (IZB Innovations- und Gründerzentrum Biotechnologie Martinsried (Fördergesellschaft IZB mbH))

Zobel, Peter Hanns (Bayern (govt) 201606 Director at IZB)


Organisation Organisation IZB Innovations- und Gründerzentrum Biotechnologie Martinsried (Fördergesellschaft IZB mbH)
  Group Bavaria (govt region)
Products Product business park management / science park management
  Product 2 BIOTECH

Fördergesellschaft IZB mbH. (6/9/16). "Press Release: Bicoll Moves into the Leading European Biotech Cluster". Planegg-Martinsried.

The biopharmaceutical company is now one of the 62 start-up companies in the Innovation Center for Biotechnology in Martinsried near Munich

Planegg / Martinsried (Germany) – June, 9th, 2016 – Today, Bicoll Group announced that it has been selected by the Fördergesellschaft IZB mbH which operates the Innovation and Start-Up Center for Biotechnology (IZB) to join the leading European center for medical biotechnology.
Along with the headquarters in Martinsried, Bicoll operates its laboratories in Shanghai, P.R. China.

"The opportunity to relocate the company's headquarters to the IZB in Martinsried supports the company’s growth enormously. The direct integration in Europe's leading biotech cluster allows Bicoll to accelerate both the current development efforts, as well as relations with other academic staff, top-management and investors on site", said Dr. Kai Lamottke, Managing Director of Bicoll GmbH.

"Bicoll has already developed a very good reputation in the field of drug development. We are happy to welcome Dr. Kai Lamottke not only as a distinguished entrepreneur, but also as an excellent networker for our globally recognized hotspot for Life Science in the IZB. As one of the first members of the Faculty Club he is contributing to the intensive networking between scientists, entrepreneurs and politicians. The IZB entrepreneurs certainly benefit from the excellent contacts that he has built up in recent years in China", explains Dr. Peter Zobel, Director of the IZB, about his decision to offer the space to Bicoll GmbH in the IZB.

Bicoll's technology supports the fastest small molecule approach from the initial screening to the first animal data; even inthe complicated settings such as for example orphan targets, rare diseases, as well as in the field of plant protection, nutraceuticals and cosmetics. Bicoll's starting points for the drug development have higher chances to succeed - to make the entire process from the early stage drug development to the product.

The enterprise company IZB GmbH, established in 1995, is the operator of the Innovation and Start-up Center for Biotechnology in Planegg-Martinsried and Freising-Weihenstephan and is one of the top ten biotechnology centers in the world. 62 biotech companies with more than 650 employees operate in 26,000 m2. An important criterion for the success of IZBs is the proximity to excellence of the Ludwig-Maximilian University and the renowned research institutions involved in biotechnology on campus Martinsried, such as the Max Planck Institutes of Biochemistry and Neurobiology. The enterprise company IZB mbH is a subsidiary of Bavaria State. The aim is to support the creation of life science companies and contribute by leasing out suitable premises for the economic implementation of research results in the field of life science. Therefore young entrepreneurs and company founders in the field life science find here an optimal infrastructure for economic implementation of their product or service ideas. The IZB supports its companies with financing, business issues, partners search, negotiations in the scientific network, trade fairs and marketing activities and conversions.


Bicoll is a biopharmaceutical company, offering pre-clinical support in the area of Drug Discovery from Natural Products (ProfilesTM) and Medicinal Chemistry. Dedicated to the discovery and optimization of the highest quality lead compounds, Bicoll provides an efficient, multi-disciplinary approach to drug discovery. With outstanding expertise in high tech natural product chemistry and validated experience in medicinal chemistry, Bicoll increases quality and quantity of the drug discovery pipeline of its partner's candidates portfolio.

The Bicoll Group provides its services to a number of international clients of various fields of interest, e.g. pharmaceutical and agrochemical industry. Bicoll comprises two legal entities: Bicoll GmbH in Planegg / Martinsried, Germany and its 100% daughter company Bicoll Biotechnology (Shanghai) Co. Ltd., P.R. China. Technology development, cooperation management and marketing are functions in Martinsried, while facilities for research and development are located in Shanghai. Currently Bicoll employs 40 people at both locations. More at and LinkedIn.

Media contact of Bicoll

Maria Lamottke, Public relations manager
Tel.: 0049 89820 10630, email:
Follow us @BicollGroup

Innovation Center for Biotechnology (IZB)

The enterprise company IZB mbH, established in 1995, is the operator of the Innovation and Start-up Center for Biotechnology in Planegg-Martinsried and Freising-Weihenstephan and has evolved into one of the top ten biotech centers in the world. 62 biotech companies with more than 650 employees operate in 26,000 m2. The companies are working on the development of drugs to cure the most serious diseases such as cancer, Alzheimer's disease and various autoimmune diseases. In IZB Freising-Weihenstephan - 15 minutes from the Munich International Airport - scientists deal with developments in the life sciences. An important criterion for the success of IZBs is the proximity to the excellent cutting-edge research on campus in Martinsried / Großhadern and Munich area. Above all, the new local infrastructure such as the Faculty Club G2B, the IZB Residence CAMPUS AT HOME, chemistry school Elhardt, the two kindergartens BioKids and BioKids2 and the two restaurants SEVEN AND MORE and Café Freshmaker have become the decisive factor. More info at

Media contact of IZB

Susanne Simon, Head of public relations department
Fördergesellschaft IZB mbH, Innovations- and Start-Up Center for Biotechnology
Am Klopferspitz 19, D-82152 Planegg-Martinsried
Tel.: 0049 89/55 279 48-17, Fax: 0049 89/55 279 48-29, Mobil: 0049 172/86 66 093

Record changed: 2017-06-03


Picture [iito] Männer Ballett 650x80px

More documents for Peter Hanns Zobel

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top